Moderna raises 2026 outlook as CEO says newer vaccines are gaining traction
CNBC Moderna Boosts Revenue Guidance on Covid Vaccine Sales Bloomberg.com Moderna Reports Third Quarter 2026 Financial Results and Provides Business Updates Yahoo Finance Moderna Stock Is Up 700% on Cancer Vaccine Hype. Earnings Reveal That Covid Still…
The report was published on 06 de novembro de 2026 às 08:47 by CNBC and is part of the Business coverage.
What other outlets are saying
- CNBC: Moderna raises 2026 outlook as CEO says newer vaccines are gaining traction
- WSJ: Moderna Swings to Profit, Lifts Outlook as Covid-19 Vaccine Demand Stabilizes
- MarketWatch: Moderna’s stock jumps after biotech raises sales outlook
- USA Today: Health Canada Authorizes Moderna's mRNA Influenza and Combination Influenza and COVID-19 Vaccines
- Toronto Star: Health Canada approves Moderna’s mRNA flu and flu-COVID combo vaccines
Quick answers
Who reported this story?
It was first reported by CNBC on 06 de novembro de 2026 às 08:47.
What is the category?
It is filed under Business on Rio Warzone News.
